All publications and patent applications mentioned in this specification are incorporated herein by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The present invention relates to medical devices in general, and in particular to devices for supporting internal body organs.
The mitral valve is a portion of the heart that is located between the chambers of the left atrium and the left ventricle. When the left ventricle contracts to pump blood throughout the body, the mitral valve closes to prevent the blood being pumped back into the left atrium. In some patients, whether due to genetic malformation, disease or injury, the mitral valve fails to close properly causing a condition known as regurgitation, whereby blood is pumped into the atrium upon each contraction of the heart muscle. Regurgitation is a serious, often rapidly deteriorating, condition that reduces circulatory efficiency and must be corrected.
Two of the more common techniques for restoring the function of a damaged mitral valve are to surgically replace the valve with a mechanical valve or to suture a flexible ring around the valve to support it. Each of these procedures is highly invasive because access to the heart is obtained through an opening in the patient's chest. Patients with mitral valve regurgitation are often relatively frail thereby increasing the risks associated with such an operation.
One less invasive approach for aiding the closure of the mitral valve involves the placement of a support structure in the cardiac sinus and vessel that passes adjacent the mitral valve. The support structure is designed to push the vessel and surrounding tissue against the valve to aid its closure. This technique has the advantage over other methods of mitral valve repair because it can be performed percutaneously without opening the chest wall. While this technique appears promising, some proposed supports appear to limit the amount of blood that can flow through the coronary sinus and may contribute to the formation of thrombosis in the vessel. Therefore, there is a need for a tissue support structure that does not inhibit the flow of blood in the vessel in which it is placed and reduces the likelihood of thrombosis formation. Furthermore, the device should be flexible and securely anchored such that it moves with the body and can adapt to changes in the shape of the vessel over time.
The present invention is an intravascular support that is designed to change the shape of a body organ that is adjacent to a vessel in which the support is placed. In one embodiment of the invention, the support is designed to aid the closure of a mitral valve. The support is placed in a coronary sinus and vessel that are located adjacent the mitral valve and urges the vessel wall against the valve to aid its closure.
The intravascular support of the present invention includes a proximal and distal anchor and a support wire or reshaper disposed therebetween. The proximal and distal anchors circumferentially engage a vessel in which the support is placed. A support wire is urged against the vessel by the proximal and distal anchors to support the tissue adjacent the vessel.
In one embodiment of the invention, the proximal and distal supports are made from a wire hoop that presents a low metal coverage area to blood flowing within the vessel. The wire hoops may allow tissue to grow over the anchors to reduce the chance of thrombosis formation. The wire hoops have a figure eight configuration and can expand to maintain contact with the vessel walls if no vessel expands or changes shape.
In another embodiment of the invention, the proximal and distal anchors of the intravascular support are rotationally offset from each other. Locks on the support wire allow a physician to ensure that the anchors have been successfully deployed and prevent the support wire from collapsing within a vessel.
The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
As indicated above, the present invention is a medical device that supports or changes the shape of tissue that is adjacent a vessel in which the device is placed. The present invention can be used in any location in the body where the tissue needing support is located near a vessel in which the device can be deployed. The present invention is particularly useful in supporting a mitral valve in an area adjacent a coronary sinus and vessel. Therefore, although the embodiments of the invention described are designed to support a mitral valve, those skilled in the art will appreciate that the invention is not limited to use in supporting a mitral valve.
As will be explained in further detail below, each of the proximal and distal anchors 52, 54 preferably circumferentially engages the wall of the vessel 60 in which it is placed. The support wire 56 is secured to a peripheral edge of the proximal and distal anchors such that the support wire is urged by the anchors against the vessel wall. Therefore, the support wire 56 and anchors 52, 54 present a minimal obstruction to blood flowing within the vessel.
In one embodiment of the invention, the support wire 102 comprises a double length of nitinol wire that has both ends positioned within a distal crimp tube 108. To form the support wire 102, the wire extends distally from the crimp tube 108 where it is bent to form a distal stop loop (see 121 in
Support wire 102 has a length that is selected based on its intended destination within a patient's vessel. For use in supporting a mitral valve, the support wire is preferably between one and six inches long and has a curved bend between its proximal end 104 and distal end 106 with a radius of curvature between 1 and 3 inches and most preferably with a radius of curvature of 1.8 inches. In addition, the wire used to form the support wire 102 is flexible enough to move with each heartbeat (thereby changing the force applied to the mitral valve annulus during the heartbeat) and stiff enough to support the mitral valve. In one embodiment, the wire used to form the support wire 102 is made of nitinol having a modulus of elasticity of 5-20×106 psi and a diameter of between 0.0110″ and 0.0150″ and most preferably 0.0140″. Other shape memory materials may be used for support wire as well.
At the distal end of the support wire 102 is a distal anchor 120 that is formed of a flexible wire such as nitinol or some other shape memory material. As is best shown in
The distal anchor is expanded by sliding the double eyelet 122 of the distal anchor from a position that is proximal to the distal lock 110 on the support wire to a position that is distal to the distal lock 110. The bent-out portions 110a and 110b of support wire 110 are spaced wider than the width of double eyelet 122 and provide camming surfaces for the locking action. Distal movement of eyelet 122 pushes these camming surfaces inward to permit eyelet 122 to pass distally of the lock 110, then return to their original spacing to keep eyelet 122 in the locked position.
The dimensions of the distal anchor are selected so that the diameter of the distal anchor in a plane perpendicular to the axis of the lumen in which the anchor is deployed is preferably between 100% and 300%, most preferably between 130% and 200%, of the diameter of the lumen prior to deployment. When treating mitral valve regurgitation by placement of the device in the coronary sinus, the diameter of the coronary sinus may expand over time after deployment. Oversizing the anchor combined with the inherent deformability and recoverability properties of the anchor material (particularly nitinol or some other shape memory material) enables the anchor to continue to expand from its initial deployment size as the lumen distends and expands over time.
Upon expansion, the distal anchor circumferentially engages the vessel wall with a radially outwardly directed force that is distributed unequally around the circumference of the anchor by distending the vessel wall in variable amounts along the axial length of the anchor. The unequal distribution of force helps the anchor contact the lumen wall securely by creating bumps and ridges that are not parallel to the central axis of the lumen. In its expanded configuration the distal anchor's diameter is at least 50%-500% and most preferably 100%-300% of the anchor's diameter in the unexpanded configuration. The open cross-sectional area of the lumen through the anchor is at least 50% and most preferably 80%-100% of the lumen cross sectional area prior to redeployment of the anchor.
In addition, the metal coverage of the anchor, as defined by the percentage of the lumen surface area through which the anchor extends that is exposed to a metal surface, is between 5% and 30% and most preferably 10%. The wire used to form the distal anchor 120 is preferably nitinol having a diameter of between 0.0110″ and 0.0150″ and most preferably 0.0140 inches. Other shape memory materials may be used as well.
During insertion, a physician can tactilely feel when the eyelet 122 has been slid over the distal lock 110 in order to determine when the distal anchor has been set within a vessel lumen. In addition, if the anchor is misplaced, it can be collapsed by pulling the eyelet 122 proximally over the distal lock 110 and repositioning the anchor in the unexpanded configuration. The force required to capture the distal anchor is preferably less than 20 lbs. and more preferably less than 10 lbs.
At the proximal end of the intravascular support is a proximal anchor 140 that is preferably formed of a biocompatible, elastic wire such as stainless steel or a shape memory material such as nitinol. As is best shown in
Like the distal anchor, the proximal anchor is expanded and locked by sliding the double eyelet 142 of the proximal anchor from a position that is proximal to the proximal lock 114 on the support wire to a position that is distal to the proximal lock 114. As can be seen in
As can be seen by comparing the proximal anchor 140 with the distal anchor 120 in
Upon expansion, the proximal anchor circumferentially engages the vessel wall with a radially outwardly directed force that is distributed unequally around the circumference of the anchor by distending the vessel wall in variable amounts along the axial length of the anchor. As with the distal anchor, the unequal distribution of force helps the proximal anchor contact the lumen wall securely by creating bumps and ridges that are not parallel to the central axis of the lumen. In its expanded configuration the proximal anchor's diameter is at least 50%-500% and most preferably 100%-300% of the anchor's diameter in the unexpanded configuration. The open cross-sectional area of the lumen through the anchor is at least 50% and most preferably 80%-100% of the lumen cross sectional area prior to redeployment of the anchor.
In one embodiment of the invention, the proximal and distal anchors are oriented such that the planes of the anchors are offset with respect to each other by an angle of approximately 30 degrees. The offset helps the intravascular support 100 seat itself in the coronary sinus and vessel surrounding the mitral valve in certain mammals. However, it will be appreciated that if the support is designed for other uses, the proximal and distal anchors may be offset by more or less depending upon the anatomy of the intended destination.
In another embodiment, the distal and proximal anchors are attached to the support wire by a wire, such as nitinol wire or other shape memory material. The attaching wire may be spiral wrapped around the base of each anchor and around the support wire. In another embodiment, each anchor may be attached to the support wire by wrapping the anchor wire around the support wire. In yet another embodiment, the two anchors and the support wire may be made from a single wire, such as nitinol wire or other shape memory material.
In many contexts, it is important for the device to occupy as little of the lumen as possible. For example, when using the device and method of this invention to treat mitral valve regurgitation, the device should be as open as possible to blood flow in the coronary sinus (and to the introduction of other medical devices, such as pacing leads) while still providing the support necessary to reshape the mitral valve annulus through the coronary sinus wall. The combination of the device's open design and the use of nitinol or some other shape memory material enables the invention to meet these goals. When deployed in the coronary sinus or other lumen, the device preferably occupies between about 1.5% and about 5.5% of the overall volume of the section of lumen in which it is deployed.
In many embodiments of the invention, the use of a shape memory material such as nitinol is particularly important. The percentage of shape memory material by volume in the device is preferably between about 30% and 100%, most preferably between about 40% and 60%.
In some instances it may be necessary to move or remove an intravascular support after deployment by recapturing the device into a catheter. Prior to deployment of the proximal anchor, the distal anchor may be recaptured into the delivery catheter by simultaneously holding the device in place with tether 201 while advancing catheter distally over distal anchor 120 so that the entire device is once again inside catheter 200. The distally directed force of the catheter collapses distal anchor 120 into a size small enough to fit into catheter 200 again. Likewise, after deployment of both anchors but prior to releasing the securement mechanism as described above, the intravascular support may be recaptured into the delivery catheter by simultaneously holding the device in place with tether 201 while advancing catheter distally first over proximal anchor 140, over support wire 102, and finally over distal anchor 120. The distally directed forced of catheter 200 collapses anchors 120 and 140 into a size small enough to fit into catheter 200 again. If the securement mechanism has been detached from the device prior to recapture, the device still may be recaptured into the delivery catheter or another catheter by grasping the proximal end of the device with a grasper or tether and by advancing the catheter distally over the device.
In one embodiment of the invention, proximal anchor 140 includes a recapture guidance and compression element. In the embodiment shown in
Likewise, the two proximal arms 123 and 124 of distal anchor 120 have a shallower slope in their proximal portions 145 and 146 and an increased slope in more distal portions 147 and 148. While recapture of the distal anchor is somewhat easier due to its smaller size compared to the proximal anchor, this recapture guidance and compression feature enhances the ease with which recapture is performed.
As shown in
The proximal anchor 306 is formed from a separate wire as shown in
While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the scope of the invention. Therefore, the scope of the invention is to be determined from the following claims and equivalents thereto.
This application is a continuation of U.S. application Ser. No. 16/526,843, filed Jul. 30, 2019, which is a continuation of U.S. application Ser. No. 11/782,527, filed Jul. 24, 2007, which is a divisional of U.S. application Ser. No. 10/429,172, filed May 2, 2003, now abandoned, entitled “Device and Method for Modifying the Shape of a Body Organ,” each of which is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3620212 | Fannon, Jr. et al. | Nov 1971 | A |
3786806 | Johnson et al. | Jan 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3974526 | Dardik et al. | Aug 1976 | A |
3995623 | Blake et al. | Dec 1976 | A |
4055861 | Carpentier et al. | Nov 1977 | A |
4164046 | Cooley | Aug 1979 | A |
4485816 | Krumme | Dec 1984 | A |
4550870 | Krumme et al. | Nov 1985 | A |
4588395 | Lemelson | May 1986 | A |
4830023 | de Toledo et al. | May 1989 | A |
5061277 | Carpentier et al. | Oct 1991 | A |
5099838 | Bardy | Mar 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5197978 | Hess | Mar 1993 | A |
5250071 | Palermo | Oct 1993 | A |
5261916 | Engelson | Nov 1993 | A |
5265601 | Mehra | Nov 1993 | A |
5344426 | Lau et al. | Sep 1994 | A |
5350420 | Cosgrove et al. | Sep 1994 | A |
5411549 | Peters | May 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5441515 | Khosravi et al. | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5454365 | Bonutti | Oct 1995 | A |
5458615 | Klemm et al. | Oct 1995 | A |
5474557 | Mai | Dec 1995 | A |
5507295 | Skidmore | Apr 1996 | A |
5507802 | Imran | Apr 1996 | A |
5514161 | Limousin | May 1996 | A |
5554177 | Kieval et al. | Sep 1996 | A |
5562698 | Parker | Oct 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5584867 | Limousin et al. | Dec 1996 | A |
5601600 | Ton | Feb 1997 | A |
5609605 | Marshall | Mar 1997 | A |
5617854 | Munsif | Apr 1997 | A |
5662703 | Yurek et al. | Sep 1997 | A |
5676671 | Inoue | Oct 1997 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5733328 | Fordenbacher | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5752969 | Cunci et al. | May 1998 | A |
5800519 | Sandock | Sep 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5836882 | Frazin | Nov 1998 | A |
5871501 | Leschinsky et al. | Feb 1999 | A |
5891193 | Robinson et al. | Apr 1999 | A |
5895391 | Famholtz | Apr 1999 | A |
5899882 | Waksman et al. | May 1999 | A |
5908404 | Elliot | Jun 1999 | A |
5928258 | Khan et al. | Jul 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5954761 | Machek et al. | Sep 1999 | A |
5961545 | Lentz et al. | Oct 1999 | A |
5978705 | KenKnight et al. | Nov 1999 | A |
5984944 | Forber | Nov 1999 | A |
6001118 | Daniel et al. | Dec 1999 | A |
6007519 | Rosselli | Dec 1999 | A |
6015402 | Sahota | Jan 2000 | A |
6022371 | Killion | Feb 2000 | A |
6027517 | Crocker et al. | Feb 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6053900 | Brown et al. | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6077295 | Limon et al. | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6096064 | Routh | Aug 2000 | A |
6099549 | Bosma et al. | Aug 2000 | A |
6099552 | Adams | Aug 2000 | A |
6129755 | Mathis et al. | Oct 2000 | A |
6159220 | Gobron et al. | Dec 2000 | A |
6162168 | Schweich, Jr. et al. | Dec 2000 | A |
6171320 | Monassevitch | Jan 2001 | B1 |
6183512 | Howanec et al. | Feb 2001 | B1 |
6190406 | Duerig et al. | Feb 2001 | B1 |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6210432 | Solem et al. | Apr 2001 | B1 |
6228098 | Kayan et al. | May 2001 | B1 |
6241757 | An et al. | Jun 2001 | B1 |
6254628 | Wallace et al. | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6275730 | KenKnight et al. | Aug 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6312446 | Huebsch et al. | Nov 2001 | B1 |
6334864 | Amplatz et al. | Jan 2002 | B1 |
6342067 | Mathis et al. | Jan 2002 | B1 |
6345198 | Mouchawar et al. | Feb 2002 | B1 |
6352553 | van der Burg et al. | Mar 2002 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6358195 | Green et al. | Mar 2002 | B1 |
6368345 | Dehdashtian et al. | Apr 2002 | B1 |
6395017 | Dwyer et al. | May 2002 | B1 |
6402781 | Langberg et al. | Jun 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6442427 | Boute et al. | Aug 2002 | B1 |
6464720 | Boatman et al. | Oct 2002 | B2 |
6478776 | Rosenman et al. | Nov 2002 | B1 |
6503271 | Duerig et al. | Jan 2003 | B2 |
6537314 | Langberg et al. | Mar 2003 | B2 |
6556873 | Smits | Apr 2003 | B1 |
6562066 | Martin | May 2003 | B1 |
6562067 | Mathis | May 2003 | B2 |
6569198 | Wilson et al. | May 2003 | B1 |
6589208 | Ewers et al. | Jul 2003 | B2 |
6599314 | Mathis et al. | Jul 2003 | B2 |
6602288 | Cosgrove et al. | Aug 2003 | B1 |
6602289 | Colvin et al. | Aug 2003 | B1 |
6623521 | Steinke et al. | Sep 2003 | B2 |
6626899 | Houser et al. | Sep 2003 | B2 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6629994 | Gomez et al. | Oct 2003 | B2 |
6643546 | Mathis et al. | Nov 2003 | B2 |
6648881 | KenKnight et al. | Nov 2003 | B2 |
6652538 | Kayan et al. | Nov 2003 | B2 |
6652571 | White | Nov 2003 | B1 |
6656221 | Taylor et al. | Dec 2003 | B2 |
6676702 | Mathis | Jan 2004 | B2 |
6689164 | Seguin | Feb 2004 | B1 |
6709425 | Gambale et al. | Mar 2004 | B2 |
6716158 | Raman et al. | Apr 2004 | B2 |
6718985 | Hlavka et al. | Apr 2004 | B2 |
6721598 | Helland et al. | Apr 2004 | B1 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6733521 | Chobotov et al. | May 2004 | B2 |
6743219 | Dwyer et al. | Jun 2004 | B1 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6773446 | Dwyer et al. | Aug 2004 | B1 |
6776784 | Ginn | Aug 2004 | B2 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6793673 | Kowalsky et al. | Sep 2004 | B2 |
6797001 | Mathis et al. | Sep 2004 | B2 |
6800090 | Alferness et al. | Oct 2004 | B2 |
6805128 | Pless et al. | Oct 2004 | B1 |
6810882 | Langberg et al. | Nov 2004 | B2 |
6814752 | Chuter | Nov 2004 | B1 |
6821297 | Snyders | Nov 2004 | B2 |
6824562 | Mathis et al. | Nov 2004 | B2 |
6827690 | Bardy | Dec 2004 | B2 |
6881220 | Edwin et al. | Apr 2005 | B2 |
6890353 | Cohn et al. | May 2005 | B2 |
6899734 | Castro et al. | May 2005 | B2 |
6908478 | Alferness et al. | Jun 2005 | B2 |
6908482 | McCarthy et al. | Jun 2005 | B2 |
6926690 | Renati | Aug 2005 | B2 |
6935404 | Duerig et al. | Aug 2005 | B2 |
6949122 | Adams et al. | Sep 2005 | B2 |
6955689 | Ryan et al. | Oct 2005 | B2 |
6960229 | Mathis et al. | Nov 2005 | B2 |
6964683 | Kowalsky et al. | Nov 2005 | B2 |
6966926 | Mathis | Nov 2005 | B2 |
6976995 | Mathis et al. | Dec 2005 | B2 |
7004958 | Adams et al. | Feb 2006 | B2 |
7087064 | Hyde | Aug 2006 | B1 |
7128073 | van der Burg et al. | Oct 2006 | B1 |
7152605 | Khairkhahan et al. | Dec 2006 | B2 |
7175653 | Gaber | Feb 2007 | B2 |
7179282 | Alferness et al. | Feb 2007 | B2 |
7270676 | Alferness et al. | Sep 2007 | B2 |
7309354 | Mathis et al. | Dec 2007 | B2 |
7311729 | Mathis et al. | Dec 2007 | B2 |
7316708 | Gordon et al. | Jan 2008 | B2 |
7364588 | Mathis et al. | Apr 2008 | B2 |
7452375 | Mathis et al. | Nov 2008 | B2 |
7503931 | Kowalsky et al. | Mar 2009 | B2 |
7591826 | Alferness et al. | Sep 2009 | B2 |
7608102 | Adams et al. | Oct 2009 | B2 |
7635387 | Reuter et al. | Dec 2009 | B2 |
7674287 | Alferness et al. | Mar 2010 | B2 |
7758639 | Mathis | Jul 2010 | B2 |
7814635 | Gordon | Oct 2010 | B2 |
7828841 | Mathis et al. | Nov 2010 | B2 |
7828842 | Nieminen et al. | Nov 2010 | B2 |
7828843 | Alferness et al. | Nov 2010 | B2 |
7837728 | Nieminen et al. | Nov 2010 | B2 |
7837729 | Gordon et al. | Nov 2010 | B2 |
7887582 | Mathis et al. | Feb 2011 | B2 |
8006594 | Hayner et al. | Aug 2011 | B2 |
8062358 | Mathis et al. | Nov 2011 | B2 |
8075608 | Gordon et al. | Dec 2011 | B2 |
8172898 | Alferness et al. | May 2012 | B2 |
8182529 | Gordon et al. | May 2012 | B2 |
8250960 | Hayner et al. | Aug 2012 | B2 |
8439971 | Reuter et al. | May 2013 | B2 |
8974525 | Nieminen et al. | Mar 2015 | B2 |
9320600 | Nieminen et al. | Apr 2016 | B2 |
9408695 | Mathis et al. | Aug 2016 | B2 |
9474608 | Mathis et al. | Oct 2016 | B2 |
9526616 | Nieminen et al. | Dec 2016 | B2 |
9597186 | Nieminen et al. | Mar 2017 | B2 |
9827098 | Mathis et al. | Nov 2017 | B2 |
9827099 | Mathis et al. | Nov 2017 | B2 |
9827100 | Mathis et al. | Nov 2017 | B2 |
9956076 | Mathis et al. | May 2018 | B2 |
9956077 | Nieminen et al. | May 2018 | B2 |
10052205 | Mathis et al. | Aug 2018 | B2 |
10166102 | Nieminen et al. | Jan 2019 | B2 |
10327900 | Mathis et al. | Jun 2019 | B2 |
10449048 | Nieminen et al. | Oct 2019 | B2 |
10456257 | Mathis et al. | Oct 2019 | B2 |
10456259 | Mathis et al. | Oct 2019 | B2 |
11033257 | Nieminen et al. | Jun 2021 | B2 |
11109971 | Nieminen et al. | Sep 2021 | B2 |
20010018611 | Solem et al. | Aug 2001 | A1 |
20010041899 | Foster | Nov 2001 | A1 |
20010044568 | Langberg et al. | Nov 2001 | A1 |
20010049558 | Liddicoat et al. | Dec 2001 | A1 |
20020010507 | Ehr et al. | Jan 2002 | A1 |
20020016628 | Langberg et al. | Feb 2002 | A1 |
20020042621 | Liddicoat et al. | Apr 2002 | A1 |
20020042651 | Liddicoat et al. | Apr 2002 | A1 |
20020049468 | Streeter et al. | Apr 2002 | A1 |
20020055774 | Liddicoat | May 2002 | A1 |
20020065554 | Streeter | May 2002 | A1 |
20020095167 | Liddicoat et al. | Jul 2002 | A1 |
20020138044 | Streeter et al. | Sep 2002 | A1 |
20020151961 | Lashinski et al. | Oct 2002 | A1 |
20020156526 | Hlavka et al. | Oct 2002 | A1 |
20020161377 | Rabkin et al. | Oct 2002 | A1 |
20020161393 | Demond et al. | Oct 2002 | A1 |
20020183837 | Streeter et al. | Dec 2002 | A1 |
20020183838 | Liddicoat et al. | Dec 2002 | A1 |
20020183841 | Cohn et al. | Dec 2002 | A1 |
20020188170 | Santamore et al. | Dec 2002 | A1 |
20020193827 | McGuckin et al. | Dec 2002 | A1 |
20030018358 | Saadat | Jan 2003 | A1 |
20030040771 | Hyodoh et al. | Feb 2003 | A1 |
20030069636 | Solem et al. | Apr 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078654 | Taylor et al. | Apr 2003 | A1 |
20030083613 | Schaer | May 2003 | A1 |
20030088305 | Van Schie et al. | May 2003 | A1 |
20030093148 | Bolling et al. | May 2003 | A1 |
20030130730 | Cohn et al. | Jul 2003 | A1 |
20030135267 | Solem et al. | Jul 2003 | A1 |
20040019377 | Taylor et al. | Jan 2004 | A1 |
20040039443 | Solem et al. | Feb 2004 | A1 |
20040073302 | Rourke et al. | Apr 2004 | A1 |
20040098116 | Callas et al. | May 2004 | A1 |
20040102839 | Cohn et al. | May 2004 | A1 |
20040102840 | Solem et al. | May 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040133220 | Lashinski et al. | Jul 2004 | A1 |
20040133240 | Adams et al. | Jul 2004 | A1 |
20040133273 | Cox | Jul 2004 | A1 |
20040138744 | Lashinski et al. | Jul 2004 | A1 |
20040148019 | Vidlund et al. | Jul 2004 | A1 |
20040148020 | Vidlund et al. | Jul 2004 | A1 |
20040148021 | Cartledge et al. | Jul 2004 | A1 |
20040153147 | Mathis | Aug 2004 | A1 |
20040158321 | Reuter et al. | Aug 2004 | A1 |
20040172046 | Hlavka et al. | Sep 2004 | A1 |
20040176840 | Langberg | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040193260 | Alferness et al. | Sep 2004 | A1 |
20040220654 | Mathis et al. | Nov 2004 | A1 |
20040220657 | Nieminen et al. | Nov 2004 | A1 |
20040260342 | Vargas et al. | Dec 2004 | A1 |
20050004667 | Swinford et al. | Jan 2005 | A1 |
20050027351 | Reuter et al. | Feb 2005 | A1 |
20050033419 | Alferness et al. | Feb 2005 | A1 |
20050038506 | Webler | Feb 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050096740 | Langberg et al. | May 2005 | A1 |
20050107810 | Morales et al. | May 2005 | A1 |
20050137449 | Nieminen et al. | Jun 2005 | A1 |
20050137450 | Aronson et al. | Jun 2005 | A1 |
20050137451 | Gordon et al. | Jun 2005 | A1 |
20050149182 | Alferness et al. | Jul 2005 | A1 |
20050197692 | Pai et al. | Sep 2005 | A1 |
20050197693 | Pai et al. | Sep 2005 | A1 |
20050197694 | Pai et al. | Sep 2005 | A1 |
20050209690 | Mathis et al. | Sep 2005 | A1 |
20050216077 | Mathis et al. | Sep 2005 | A1 |
20050261704 | Mathis | Nov 2005 | A1 |
20050272969 | Alferness et al. | Dec 2005 | A1 |
20060030882 | Adams et al. | Feb 2006 | A1 |
20060041305 | Lauterjung | Feb 2006 | A1 |
20060116758 | Swinford et al. | Jun 2006 | A1 |
20060142854 | Alferness et al. | Jun 2006 | A1 |
20060161169 | Nieminen et al. | Jul 2006 | A1 |
20060167544 | Nieminen et al. | Jul 2006 | A1 |
20060271174 | Nieminen et al. | Nov 2006 | A1 |
20070066879 | Mathis et al. | Mar 2007 | A1 |
20070239270 | Mathis et al. | Oct 2007 | A1 |
20080015407 | Mathis et al. | Jan 2008 | A1 |
20080015679 | Mathis et al. | Jan 2008 | A1 |
20080015680 | Mathis et al. | Jan 2008 | A1 |
20100280602 | Mathis | Nov 2010 | A1 |
20110066234 | Gordon et al. | Mar 2011 | A1 |
20110106117 | Mathis et al. | May 2011 | A1 |
20120123532 | Mathis | May 2012 | A1 |
20120197389 | Alferness et al. | Aug 2012 | A1 |
20170189185 | Nieminen et al. | Jul 2017 | A1 |
20180256330 | Wypych | Sep 2018 | A1 |
20190336290 | Mathis et al. | Nov 2019 | A1 |
20190350708 | Mathis et al. | Nov 2019 | A1 |
20190365537 | Wypych | Dec 2019 | A1 |
20200008943 | Mathis et al. | Jan 2020 | A1 |
20200253732 | Nieminen et al. | Aug 2020 | A1 |
Number | Date | Country |
---|---|---|
0893133 | Jan 1999 | EP |
0903110 | Mar 1999 | EP |
0968688 | Jan 2000 | EP |
1050274 | Nov 2000 | EP |
1095634 | May 2001 | EP |
1177779 | Feb 2002 | EP |
2181670 | May 2010 | EP |
0741604 | Dec 1955 | GB |
2754067 | Mar 1998 | JP |
2000-308652 | Nov 2000 | JP |
2001-503291 | Mar 2001 | JP |
2003-503101 | Jan 2003 | JP |
2003-521310 | Jul 2003 | JP |
9902455 | Dec 2000 | SE |
WO9856435 | Dec 1998 | WO |
WO0044313 | Aug 2000 | WO |
WO0060995 | Oct 2000 | WO |
WO0074603 | Dec 2000 | WO |
WO0100111 | Jan 2001 | WO |
WO0118292 | Mar 2001 | WO |
WO0150985 | Jul 2001 | WO |
WO0154618 | Aug 2001 | WO |
WO0187180 | Nov 2001 | WO |
WO0200099 | Jan 2002 | WO |
WO0201999 | Jan 2002 | WO |
WO0205888 | Jan 2002 | WO |
WO0219951 | Mar 2002 | WO |
WO0234118 | May 2002 | WO |
WO0247539 | Jun 2002 | WO |
WO02053206 | Jul 2002 | WO |
WO02060352 | Aug 2002 | WO |
WO02062263 | Aug 2002 | WO |
WO02062270 | Aug 2002 | WO |
WO02062408 | Aug 2002 | WO |
WO02076284 | Oct 2002 | WO |
WO02078576 | Oct 2002 | WO |
WO02096275 | Dec 2002 | WO |
WO03015611 | Feb 2003 | WO |
WO03037171 | May 2003 | WO |
WO03049647 | Jun 2003 | WO |
WO03049648 | Jun 2003 | WO |
WO03055417 | Jul 2003 | WO |
WO03059198 | Jul 2003 | WO |
WO03063735 | Aug 2003 | WO |
WO2004045463 | Jun 2004 | WO |
WO2004084746 | Oct 2004 | WO |
Entry |
---|
El-Maasarany et al.; The coronary sinus conduit function: Anatomical study (relationsnip to adjacent structures); http://europace.oxfordjournals.org/cge/content/full/7/5/475. (accessed Sep. 9, 2008). |
Gray, H. Anatomy of the Human Body. The Systemic Veins, Philadelphia: Lea & Febiger, 1918; Bartleby.com. 2000. Available at www.bartleby.com/107/. Accessed Jun. 7, 2006. |
Heartsite.com. Echocardiogram, 1999; p. 1-4. A.S.M. Systems Inc. Available at: http://www.heartsite.com/html/echocardiogram.html. Accessed Jul. 1, 2005. |
Papageorgiou, P., et al. Coronary Sinus Pacing Prevents Induction of Atrial Fibrillation. Circulation. Sep. 16, 1997; 96(6): 1893-1898. |
Pelton et al. Medical uses of nitinol; Material Science Forum; vols. 327-328; pp. 63-70; 2000 (held in Kanazawa, Japan, May 1999). |
Pijls et al.; Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses; The New England J. of Med.; vol. 334; No. 26; pp. 1703-1708; Jun. 27, 1996. |
Pai, Suresh; U.S. Appl. No. 60/329,694 entitled “Percutaneous cardiac support structures and deployment means,” filed Oct. 16, 2001. |
Yamanouchi, et al.; Activation Mapping from the coronary sinus may be limited by anatomic variations; vol. 21 pp. 2522-2526; Nov. 1998. |
Number | Date | Country | |
---|---|---|---|
20210330460 A1 | Oct 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10429172 | May 2003 | US |
Child | 11782527 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16526843 | Jul 2019 | US |
Child | 17305559 | US | |
Parent | 11782527 | Jul 2007 | US |
Child | 16526843 | US |